Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it

Page 3 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.

• Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT06764056Not applicable
• Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility StudyRecruitingNCT06759701Early Phase 1
• Liraglutide Treatment in Obese Infertile PCOS WomenRecruitingNCT06742710Phase 4
• A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)RecruitingNCT06739122Phase 3
• Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or ObeseNot yet recruitingNCT06732245Phase 2
• Study of Tirzepatide for Recovery and Alcohol Use ManagementRecruitingNCT06727331Phase 2
• 2024 Tirzepatide-Bariatric SurgeryRecruitingNCT06721507Phase 4
• Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 DiabetesRecruitingNCT06706284Phase 4
• A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes MellitusRecruitingNCT06700538Phase 1/2
• A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related ComorbiditiesRecruitingNCT06672939Phase 3
• A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)RecruitingNCT06672549Phase 3
• Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or TirzepatideRecruitingNCT06657209Phase 4
• Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use DisorderRecruitingNCT06651177Phase 2
• Semaglutide for Helping Opioid RecoveryRecruitingNCT06639464Phase 2
• A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®Not yet recruitingNCT06633783Phase 3
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruitingNCT06632457Phase 3
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisRecruitingNCT06632444Phase 3
• GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 DiabetesRecruitingNCT06630585Phase 3
• Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 DiabetesRecruitingNCT06613854Phase 4
• The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery DiseaseRecruitingNCT06606821Phase 4
• Glucagon-Like Peptide-1 Receptor Agonist in ADPKDRecruitingNCT06582875Phase 2
• A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 DiabetesNot yet recruitingNCT06559722Phase 3
• Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and NephropathyNot yet recruitingNCT06555146Not applicable
• GLP-1R Agonist Treatment for Opioid Use DisorderRecruitingNCT06548490Phase 2
• GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver DiseaseNot yet recruitingNCT06546384Not applicable
• Mechanisms of Semaglutide Therapy in Heart Failure PatientsRecruitingNCT06541509Phase 1/2
• Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerRecruitingNCT06518837Phase 2
• Tirzepatide Weight Loss for MRD+ Early Breast CancerRecruitingNCT06517212Phase 2
• Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseRecruitingNCT06501326Phase 4
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial FibrillationRecruitingNCT06499857Phase 3
• The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic NeuropathyRecruitingNCT06461377Phase 4
• A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese SubjectsRecruitingNCT06449703Phase 1
• Semaglutide in Auto-HSCTNot yet recruitingNCT06449625Phase 2
• Prevention of Progression of Prediabetes, Obesity and CV RiskRecruitingNCT06446531Phase 1
• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)RecruitingNCT06439277Phase 3
• LIROH - Liraglutide for Obesity in HIVRecruitingNCT06438146Phase 4
• Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart FailureRecruitingNCT06423599Phase 2/3
• Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity TreatmentRecruitingNCT06411210Phase 2
• Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2RecruitingNCT06396416Phase 4
• Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension TreatmentNot yet recruitingNCT06361823Phase 3
• Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac SurgeryRecruitingNCT06361238Phase 3
• Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 DiabetesNot yet recruitingNCT06339086Phase 3
• GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving TeplizumabRecruitingNCT06338553Early Phase 1
• The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With ObesityRecruitingNCT06331286Not applicable
• GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac SurgeryRecruitingNCT06324461Phase 4
• The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced DiabetesRecruitingNCT06318442Not applicable
• Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis SuppurativaNot yet recruitingNCT06301256Not applicable
• Semaglutide 2.4mg for Low Responders After Bariatric SurgeryNot yet recruitingNCT06287307Phase 4
• Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset DiabetesRecruitingNCT06246799Phase 3
• The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic PatientsNot yet recruitingNCT06243536Phase 4
• The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot StudyRecruitingNCT06217848Early Phase 1
• Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or ObesityNot yet recruitingNCT06180616Phase 2
• Semaglutide for Post-Smoking Cessation Weight ManagementRecruitingNCT06173778Phase 2
• Subcutaneous Semaglutide in Systemic SclerodermaRecruitingNCT06149260Phase 1
• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRecruitingNCT06143956Phase 2
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 DiabetesRecruitingNCT06082063Phase 3
• Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the EndometriumRecruitingNCT06073184Phase 2
• COMMETS- Combination MCI Metabolic SyndromeRecruitingNCT06072963Phase 2
• The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic EffectRecruitingNCT06058585Phase 3
• Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolusNot yet recruitingNCT06057077Phase 1/2
• GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGHRecruitingNCT06003153Phase 4
• Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and InfertilityNot yet recruitingNCT05952882Phase 3
• Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 DiabetesNot yet recruitingNCT05950516Phase 3
• The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant RecipientsRecruitingNCT05938712Phase 2
• Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With ObesityRecruitingNCT05933499Phase 2
• Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/ObesityRecruitingNCT05912621Phase 2
• Semaglutide and Vascular RegenerationRecruitingNCT05870462Phase 4
• Trial of Semaglutide for Diabetic Kidney Disease in Type 1 DiabetesRecruitingNCT05822609Phase 2
• Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary SyndromeRecruitingNCT05819853Phase 3
• Type 1 Diabetes Impacts of Semaglutide on Cardiovascular OutcomesRecruitingNCT05819138Phase 3
• Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 DiabetesRecruitingNCT05780905Phase 4
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusRecruitingNCT05779644Not applicable
• Feasibility of Semaglutide in Advanced Lung DiseaseRecruitingNCT05746039Phase 1/2
• Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCTRecruitingNCT05708859Phase 4
• POSE2.0 With GLP-1 Agonist for Obesity ManagementRecruitingNCT05705388Not applicable
• Semaglutide Treatment for Hyperglycaemia After Renal TransplantationRecruitingNCT05702931Phase 4
• Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary SyndromeRecruitingNCT05702905Phase 4
• Effects of GH and Lirglutide on AgRPRecruitingNCT05681299Phase 4
• Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1RecruitingNCT05659368Phase 2
• Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)Not yet recruitingNCT05646199Phase 2/3
• Acute Subcutaneous SemaglutidE in Acute Ischemic sTrokeRecruitingNCT05630586Phase 2
• Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 DiabetesRecruitingNCT05597202Phase 4
• Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter SyndromeRecruitingNCT05586802Phase 3
• Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational DiabetesRecruitingNCT05569772Phase 3
• Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 DiabetesRecruitingNCT05553093Phase 4
• Adipose Tissue Heterogeneity and Its Link to Type 2 DiabetesRecruitingNCT05501483Not applicable
• Exenatide Pharmacokinetics and Pharmacodynamics in Gestational DiabetesRecruitingNCT05482789Phase 4
• Therapeutic Strategies for Microvascular Dysfunction in Type 1 DiabetesRecruitingNCT05478707Phase 2
• Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver TransplantRecruitingNCT05424003Phase 2
• Genetics of the Acute Response to Oral SemaglutideRecruitingNCT05340868Not applicable
• Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes MellitusRecruitingNCT05268237Phase 1/2
• Sit Less, Interact and Move More (SLIMM) 2 StudyRecruitingNCT05173714Phase 2
• Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DNot yet recruitingNCT05140694Phase 4
• Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With PrediabetesRecruitingNCT05119179Phase 4
• Pharmacogenetics of Response to GLP1R AgonistsRecruitingNCT05071898Phase 1
• Effect Of Semaglutide In Coronary Atheroma PlaqueNot yet recruitingNCT05071417Phase 3
• Treatment to Regress to Normoglycemia in Women with a Recent History of GDMRecruitingNCT04873050Phase 4
• Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 DiabetesRecruitingNCT04854083Phase 4
• GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose IntoleranceRecruitingNCT04731272Phase 2
• Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic SyndromeRecruitingNCT04575844Phase 4

← Glucagon-Like Peptide-1 Receptor Agonists overview